DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20164540

Knowledge, attitude and practice of pharmacovigilance among medical professionals at a tertiary care hospital in Mumbai, Maharashtra, India

Vijay M. Katekhaye, Neha G. Kadhe, James John, Sudhir R. Pawar

Abstract


Background: Many adverse drug reactions (ADRs), interactions and specific toxicities are known once drug is exposed to a larger population. Spontaneous reporting adverse events (AEs) are fundamental to a robust pharmacovigilance (PhV). Increasing physician awareness about the pharmacovigilance and ADR reporting can significantly contribute the safety of medicines. Objective of the study was to assess the knowledge, attitude and practices related to PhV among medical professionals at a tertiary care teaching hospital.

Methods: Postgraduate students (PGs) and medical teachers at a Medical College and tertiary care hospital were evaluated for their knowledge, attitude and practice of pharmacovigilance with the help of a structured questionnaire. Suggestions for improving the effectiveness of the pharmacovigilance practices were also sought.

Results: One-hundred and fifty doctors [91 (60.7%) PGs and 59 (39.3%) medical teachers] participated. Overall, 48.7% were males. 96% believed that PhV is important in medical practice but only 79.3% knew the definition of pharmacovigilance. Only 24.7% were aware of the existing nationwide pharmacovigilance program whereas the international collaborating center was known to 26% of the participants. 96% believed that it is the duty of a treating physician to report an ADR while 36.7% felt that ADR reporting should be the responsibility of a separate team. Surprisingly, 54% felt that financial aid should be provided for ADR reporting. 42.7% have not reported any ADR whilst only 16% have reported more than 10 ADRs in their career. To create an ADR database (79.3%) was the common expectation from the PhV center. 98.7% suggested continued medical education (CME) and trainings to improve the effectiveness of PhV in Indian setting.

Conclusions: Regardless of a fair attitude towards PhV, the practice of ADR reporting is poor probably because of lack of sufficient knowledge about PhV. Motivating the physicians through CMEs and trainings so as to improve and strengthen the pharmacovigilance practices is the current need in India.

Keywords


ADR, Attitude, Doctors, Knowledge, Practice, Spontaneous reporting

Full Text:

PDF

References


WHO Policy Perspectives on Medicines, Pharmacovigilance: ensuring the safe use of medicines, October 2004 World Health Organization, Geneva. Available from http://apps.who.int/ medicinedocs/ pdf/ s6164e/ s6164e.pdf Accessed on 26/09/2016.

Mehta U, Dheda M, Steel G, Blockman M, Ntilivamunda A, Maartens G, et al. Strengthening pharmacovigilance in South Africa. SAMJ. 2014;104(2):104-6.

Oberg KC. Adverse Drug Reactions. Ame J Pharma Edu. 1999;63:199-204.

British Medical Association. Reporting adverse drug reactions: a guide for healthcare professionals. 2006 May. Available from http://www.isoponline.org/wp-content/uploads/2015/01/BMAreport.pdf Accessed on 26/09/2016

Pouyanne P, Haramburu F, Imbs JL, Bégaud B. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. British Med J. 2000;320:1036.

Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clinical Pharmacology. 2009;9:14.

Bello SO, Umar MT. Knowledge and attitudes of physicians relating to reporting of adverse drug reactions in Sokoto, North-Western Nigeria. Annals of African Medicine. 2011;10(1):13-8.

Gupta P, Udupa A. Adverse Drug Reaction Reporting and Pharmacovigilance: Knowledge, Attitudes and Perceptions amongst Resident Doctors. J Pharm Sci & Res. 2011;3(2):1064-9.

Li Q, Zhang SM, Chen HT, Fang SP, Yu X, Liu D, et al. Awareness and attitudes of healthcare professional in Wuhan, China to the reporting of adverse drug reactions. Chinese Medical Journal. 2004;117(6):856-61.

WHO Essential medicines and health products: Pharmacovigilance, Available from: http://www.who.int/medicines/ areas/quality_safety/ safety_efficacy/ pharmvigi/en/ Accessed on 26/09/2016

Srinivasan R, Ramya G. Adverse drug reaction-causality assessment. Int J Res Pharm Chem. 2011;1(3):606-12.

Ramesh M, Parthasarathi G. Adverse Drug Reactions Reporting: Attitudes and Perceptions of Medical Practitioners. Asian J Pharma Clin Res. 2009;2(2):10-4.

Rehan HS, Vasudev K, Tripathi CD. Adverse drug reaction monitoring: Knowledge, attitude and practices of medical students and prescribers. Nat Med J Ind. 2002;15(1):24-6.

Bateman DN, Sanders GLS, Rawlins MD. Attitudes to adverse drug reaction reporting in the Northern Region. Br J Clin Pharmac. 1992; 34:421-6.

Tabali M, Jeschke E, Bockelbrink A, Witt CM, Willich SN, Ostermann T, et al; Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine. BMC Public Health. 2009;9:274.

Figueiras A, Herdeiro MT, Polonia J, Gestal-Otero JJ. An Educational Intervention to Improve Physician Reporting of Adverse Drug Reactions A Cluster-Randomized Controlled Trial. JAMA. 2006;296(9):1086-93.

Moride Y, Haramburu F, Requejo AA, Be´gaud B. Under-reporting of adverse drug reactions in general practice. Br J Clin Pharmacol. 1997;43:177-81.

Mirbaha F, Shalviri G, Yazdizadeh B, Gholami K, Majdzadeh R. Perceived barriers to reporting adverse drug events in hospitals: a qualitative study using theoretical domains framework approach. Implementation Science. 2015;10(1):1.

Bhagavathula AS, Elnour AA, Jamshed SQ, Shehab A. Health Professionals' Knowledge, Attitudes and Practices about Pharmacovigilance in India: A Systematic Review and Meta-Analysis. PloS one. 2016;11(3):e0152221.